Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shikhar Mehrotra

Showing results (111-120 of 116) with videos related to

Pageof 12
Sort By:
You have reached the last page of results.This site can display upto 116 results.
Cell Metabolism|November 14, 2017
CD38-NAD<sup>+</sup>Axis Regulates Immunotherapeutic Anti-Tumor T Cell ResponseShilpak Chatterjee, Anusara Daenthanasanmak, Paramita Chakraborty, et al.
Iscience|May 10, 2021
Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patientsConnor J Dwyer, Colleen A Cloud, Cindy Wang, et al.
Journal of Surgery and Research|April 12, 2024
Impaired Cellular and Antibody immunity after COVID-19 in Chronically Immunosuppressed Transplant RecipientsChethan Ashokkumar, Vinayak Rohan, Alexander H Kroemer, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipientsChethan Ashokkumar, Vinayak Rohan, Alexander H Kroemer, et al.
Nature Communications|June 2, 2026
Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axisParamita Chakraborty, Shilpak Chatterjee, Mohamed Faisal Kassir, et al.
Frontiers in Immunology|February 11, 2025
Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinomaAngela J Yoon, Richard D Carvajal, Evan M Graboyes, et al.
Pageof 12

Showing results (111-120 of 116) with videos related to

Sort By:
Pageof 12
You have reached the last page of results.This site can display upto 116 results.
Cell Metabolism|November 14, 2017
CD38-NAD<sup>+</sup>Axis Regulates Immunotherapeutic Anti-Tumor T Cell ResponseShilpak Chatterjee, Anusara Daenthanasanmak, Paramita Chakraborty, et al.
Iscience|May 10, 2021
Comparative analysis of antibodies to SARS-CoV-2 between asymptomatic and convalescent patientsConnor J Dwyer, Colleen A Cloud, Cindy Wang, et al.
Journal of Surgery and Research|April 12, 2024
Impaired Cellular and Antibody immunity after COVID-19 in Chronically Immunosuppressed Transplant RecipientsChethan Ashokkumar, Vinayak Rohan, Alexander H Kroemer, et al.
Biorxiv : the Preprint Server for Biology|May 11, 2021
Impaired T-cell and antibody immunity after COVID-19 infection in chronically immunosuppressed transplant recipientsChethan Ashokkumar, Vinayak Rohan, Alexander H Kroemer, et al.
Nature Communications|June 2, 2026
Sphingosine kinase-2 inhibition promotes immunogenic differentiation of myeloid-derived suppressor cells through an Acetyl-CoA carboxylase-phosphatidylcholine axisParamita Chakraborty, Shilpak Chatterjee, Mohamed Faisal Kassir, et al.
Frontiers in Immunology|February 11, 2025
Pilot clinical trial of neoadjuvant toll-like receptor 7 agonist (Imiquimod) immunotherapy in early-stage oral squamous cell carcinomaAngela J Yoon, Richard D Carvajal, Evan M Graboyes, et al.
Pageof 12